Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

20.75
+7.0651.57%
Post-market: 21.901.15+5.54%19:59 EST
Volume:2.84M
Turnover:54.90M
Market Cap:1.41B
PE:-18.32
High:20.80
Open:14.95
Low:14.61
Close:13.69
52wk High:22.75
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:11.47
T/O Rate:16.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1329
EPS(LYR):-0.9176
ROE:-86.99%
ROA:-48.90%
PB:15.17
PE(LYR):-22.61

Loading ...

Company Profile

Company Name:
Pulse Biosciences
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
75
Office Location:
601 Brickell Key Drive,Suite 1080,Miami,Florida,United States
Zip Code:
33131
Fax:
- -
Introduction:
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Directors

Name
Position
Paul A. LaViolette
Co-Chairman of the Board, Chief Executive Officer and President
Robert W. Duggan
Independent Director and Co-Chairman of the Board
Darrin R. Uecker
Chief Technology Officer and Director
Mahkam Zanganeh
Independent Director
Manmeet Singh Soni
Director and Lead Independent Director
Maria Sainz
Independent Director
Richard A. van den Broek
Independent Director

Shareholders

Name
Position
Paul A. LaViolette
Co-Chairman of the Board, Chief Executive Officer and President
Jon Skinner
Chief Financial Officer
Darrin R. Uecker
Chief Technology Officer and Director
Kevin P. Danahy
Chief Commercial Officer